Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2022-05-17 00:00:00 ET · period of report 2022-05-16 · accession 0001062993-22-012735 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-17 | 2022-05-16 | ACH | Pesicka Edward A | Pres, CEO, Dir | S - Sale | $35.32 | -132.6K | 1.31M | -9% | -$4.68M |
| 2022-05-17 | 2022-05-16 | ACH | Pesicka Edward A | Pres, CEO, Dir | F - Tax | $36.05 | -9,881 | 1.30M | -0.8% | -$356.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | S | D | 53,875 | $35.31 | 1,306,158 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022 (F4) Weighted average of the sale price range of $34.97 through $35.96 |
| 2 | Common | Common Stock | 2022-05-16 | S | D | 1,914 | $36.05 | 1,360,033 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022 (F3) Weighted average of the sale price range of $35.96 through $36.16 |
| 3 | Common | Common Stock | 2022-05-16 | S | D | 75,675 | $35.30 | 1,361,947 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022 (F2) Weighted average of the sale price range of $34.96 through $35.95 |
| 4 | Common | Common Stock | 2022-05-16 | F | D | 9,881 | $36.05 | 1,295,177 | D | — | — | (F6) Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. |
| 5 | Common | Common Stock | 2022-05-16 | S | D | 1,100 | $36.03 | 1,305,058 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022 (F5) Weighted average of the sale price range of $35.98 through $36.16 |